Target type: biologicalprocess
The establishment, maintenance and elaboration of an axis in the oocyte. An example of this is found in Drosophila melanogaster. [GOC:mtg_sensu, ISBN:0879694238]
Oocyte axis specification is a crucial developmental process in animals, particularly in mammals, that establishes the anterior-posterior (A-P) and dorsal-ventral (D-V) axes of the developing embryo. This process is essential for proper embryonic development, ensuring the formation of the correct body plan.
The process begins with the asymmetric localization of key determinants, including mRNAs and proteins, within the oocyte. These determinants are transported to specific regions of the oocyte cytoplasm, setting the stage for the development of distinct embryonic axes.
**A-P Axis Specification:**
* **Microtubule-mediated transport:** Microtubules, which are cytoskeletal structures, play a vital role in transporting mRNAs and proteins to their designated locations. The minus ends of microtubules are typically anchored near the nucleus, while the plus ends extend towards the oocyte periphery.
* **Par proteins:** These proteins, such as PAR-1 and PAR-2, localize to specific regions of the oocyte and establish polarity. They act as scaffolding proteins, recruiting other molecules to their respective domains.
* **Wnt signaling:** Wnt signaling pathway is activated at the posterior pole of the oocyte. This activation results in the accumulation of β-catenin, a key transcription factor, at the posterior pole. β-catenin then triggers the expression of genes involved in posterior development.
**D-V Axis Specification:**
* **oocyte-specific signaling pathways:** In mammals, the D-V axis is established later in development, during the preimplantation stages. The process involves the interplay between the oocyte and surrounding cells, such as cumulus cells.
* **Growth Differentiation Factor 9 (GDF9):** GDF9 is a protein produced by oocytes that plays a crucial role in regulating cumulus cell function. It is involved in both A-P and D-V axis specification.
* **Bone Morphogenetic Protein (BMP) signaling:** BMPs are secreted signaling molecules that are expressed in the cumulus cells. They activate the BMP signaling pathway within the oocyte, leading to the establishment of the D-V axis.
**Significance of Axis Specification:**
* **Correct body plan:** Axis specification ensures that the developing embryo forms the correct body plan, with the head at the anterior end, the tail at the posterior end, and the back at the dorsal side.
* **Proper organ development:** The correct positioning of cells and tissues along the embryonic axes is essential for the development of specific organs.
* **Embryonic viability:** Defects in axis specification can lead to severe developmental abnormalities and embryonic lethality.
Oocyte axis specification is a highly coordinated and regulated process that involves a complex interplay of molecular pathways. It is essential for establishing the proper body plan and ensuring normal embryonic development.'
"
Protein | Definition | Taxonomy |
---|---|---|
Methylosome protein 50 | A methylosome protein WDR77 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9BQA1] | Homo sapiens (human) |
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | A 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P51993] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
2,3-dihydroxybenzoic acid | 2,3-dihydroxybenzoic acid : A dihydroxybenzoic acid that is benzoic acid substituted by hydroxy groups at positions 2 and 3. It occurs naturally in Phyllanthus acidus and in the aquatic fern Salvinia molesta. 2,3-dihydroxybenzoic acid: RN given refers to parent cpd dihydroxybenzoic acid : Any member of the class of hydroxybenzoic acids carrying two phenolic hydroxy groups on the benzene ring and its derivatives. | dihydroxybenzoic acid | human xenobiotic metabolite; plant metabolite |
protocatechuic acid | 3,4-dihydroxybenzoic acid : A dihydroxybenzoic acid in which the hydroxy groups are located at positions 3 and 4. protocatechuic acid: RN given refers to parent cpd; structure | catechols; dihydroxybenzoic acid | antineoplastic agent; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor; human xenobiotic metabolite; plant metabolite |
gallic acid | gallate : A trihydroxybenzoate that is the conjugate base of gallic acid. | trihydroxybenzoic acid | antineoplastic agent; antioxidant; apoptosis inducer; astringent; cyclooxygenase 2 inhibitor; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; geroprotector; human xenobiotic metabolite; plant metabolite |
beta-resorcylic acid | beta-resorcylic acid: RN given refers to parent cpd; structure | ||
2,5-dihydroxybenzoic acid | 2,5-dihydroxybenzoic acid : A dihydroxybenzoic acid having the two hydroxy groups at the 2- and 5-positions. 2,5-dihydroxybenzoic acid: RN given refers to parent cpd; a oxidative product of saligenin | dihydroxybenzoic acid | EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; fungal metabolite; human metabolite; MALDI matrix material; mouse metabolite |
veratric acid | 3,4-dimethoxybenzoic acid : A member of the class of benzoic acids that is benzoic acid substituted by methoxy groups at positions 2 and 3. veratric acid: RN given refers to parent cpd; structure | benzoic acids | allergen; plant metabolite |
methyl gallate | methyl 3,4,5-trihydroxybenzoate : A gallate ester obtained by the formal condensation of gallic acid with methanol. It exhibits anti-oxidant, anti-tumor, anti-microbial and anti-inflammatory properties. methyl gallate: has both immunosuppressive and phytogenic antineoplastic activities; isolated from Acer saccharinum | gallate ester | anti-inflammatory agent; antioxidant; plant metabolite |
3,4,5-trimethoxybenzoic acid | 3,4,5-trimethoxybenzoic acid : A benzoic acid derivative carrying 3-, 4- and 5-methoxy substituents. 3,4,5-trimethoxybenzoic acid: RN given refers to parent cpd; structure | benzoic acids; methoxybenzenes | human urinary metabolite; human xenobiotic metabolite; plant metabolite |
syringic acid | syringic acid : A dimethoxybenzene that is 3,5-dimethyl ether derivative of gallic acid. syringic acid: RN given refers to parent cpd; structure in third source | benzoic acids; dimethoxybenzene; phenols | plant metabolite |
s-adenosylmethionine | acylcarnitine: structure in first source S-adenosyl-L-methioninate : A sulfonium betaine that is a conjugate base of S-adenosyl-L-methionine obtained by the deprotonation of the carboxy group. | sulfonium betaine | human metabolite |
epigallocatechin gallate | (-)-epigallocatechin 3-gallate : A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin. epigallocatechin gallate: a steroid 5alpha-reductase inhibitor and antimutagen in green tea (Camellia sinensis) | flavans; gallate ester; polyphenol | antineoplastic agent; antioxidant; apoptosis inducer; geroprotector; Hsp90 inhibitor; neuroprotective agent; plant metabolite |
s-adenosylhomocysteine | S-adenosyl-L-homocysteine : An organic sulfide that is the S-adenosyl derivative of L-homocysteine. S-Adenosylhomocysteine: 5'-S-(3-Amino-3-carboxypropyl)-5'-thioadenosine. Formed from S-adenosylmethionine after transmethylation reactions. | adenosines; amino acid zwitterion; homocysteine derivative; homocysteines; organic sulfide | cofactor; EC 2.1.1.72 [site-specific DNA-methyltransferase (adenine-specific)] inhibitor; EC 2.1.1.79 (cyclopropane-fatty-acyl-phospholipid synthase) inhibitor; epitope; fundamental metabolite |
5'-methylthioadenosine | 5'-methylthioadenosine: structure 5'-S-methyl-5'-thioadenosine : Adenosine with the hydroxy group at C-5' substituted with a methylthio (methylsulfanyl) group. | thioadenosine | algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
epz004777 | N-glycosyl compound | ||
gsk3235025 | GSK3235025: an inhibitor of protein arginine methyltransferase-5 (PRMT5); structure in first source | ||
guanosine diphosphate | Guanosine Diphosphate: A guanine nucleotide containing two phosphate groups esterified to the sugar moiety. | guanosine 5'-phosphate; purine ribonucleoside 5'-diphosphate | Escherichia coli metabolite; mouse metabolite; uncoupling protein inhibitor |